Evidence map›Paper›PMID 40048456›Full record

Observational studyPloS one2025

Healthcare utilization trends in adults with asthma or COPD during the first year of COVID-19 pandemic in comparison to pre-pandemic: A population-based study.

Tetyana Kendzerska, Michael Pugliese, Douglas Manuel, Mohsen Sadatsafavi, Marcus Povitz, Therese A Stukel, Teresa To, Shawn D Aaron, Sunita Mulpuru, Melanie Chin and 3 more

Abstract readObservational StudyComparative Study
In one paragraph

Observational study in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tetyana KendzerskaThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0002-5301-1796
Michael PuglieseThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Douglas ManuelThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Mohsen SadatsafaviRespiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada.
Marcus PovitzDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Therese A StukelICES, Ontario, Canada.
Teresa ToICES, Ontario, Canada.ORCID https://orcid.org/0000-0001-7463-3423
Shawn D AaronThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Sunita MulpuruThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Melanie ChinThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Claire E KendallThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Kednapa ThavornThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Andrea S GershonICES, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess how changes in outpatient services during the first year of the COVID-19 pandemic were related to acute healthcare use (emergency department or hospitalizations) for individuals with asthma or chronic obstructive pulmonary disease (COPD).

methodsWe conducted an observational study using health administrative data in Ontario (Canada) from January 2016 to March 2021 on all adults with diagnosed asthma or COPD. We used monthly time series auto-regressive integrated moving-average (ARIMA) and pre-pandemic monthly rates (January 2016 to February 2020) to calculate projected rates (i.e., a pandemic had not occurred) during the pandemic (March 2020 to March 2021), and Quasi-Poisson models with two-way interaction to estimate crude and adjusted rate ratios.

resultsIn the first pandemic year, in individuals with asthma or COPD, outpatient visit rates started lower than projected (Mar-May 2020), returned to projected in the middle of the year (Jun-Aug 2020) and then rose to higher than projected between Sep 2020 and Mar 2021: observed rates of 80,293 per 100,000 persons vs. projected 74,192 (95% CI: 68,926-79,868) in individuals with asthma, and 92,651 vs. projected 85,871 (95% CI: 79,975-92,207) in individuals with COPD. Acute care rates remained below projected during the first pandemic year. While pulmonary function test (PFT) rates remained below projected during the first pandemic year, in both populations, a decrease in acute care visits during the pandemic, compared to pre-pandemic, was noted during months with the highest PFT rates (interaction p-values < 0.0001).

conclusionsDespite asthma and COPD being ambulatory-care sensitive conditions, lower rates of outpatient visits during the beginning of the pandemic were not associated with increased rates of acute care use. Lower PFT rates were associated with higher acute care visit rates, suggesting that access to PFT during pandemic is likely important for individuals with asthma or COPD.

Indexed as

AsthmaCOVID-19Patient Acceptance of Health CarePulmonary Disease, Chronic ObstructiveAdultAgedAmbulatory CareEmergency Service, HospitalFemaleHospitalizationHumansMaleMiddle AgedOntarioPandemicsSARS-CoV-2

Identifiers

PMID40048456
PMCPMC11884700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.